Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.
BACKGROUND
Adequate zinc is critical for immune function; however, zinc deficiency occurs in >50% of human immunodeficiency virus (HIV)-infected adults. We examined the safety and efficacy of long-term zinc supplementation in relation to HIV disease progression.


METHODS
A prospective, randomized, controlled clinical trial was conducted involving 231 HIV-infected adults with low plasma zinc levels (<0.75 mg/L), who were randomly assigned to receive zinc (12 mg of elemental zinc for women and 15 mg for men) or placebo for 18 months. The primary end point was immunological failure. HIV viral load and CD4(+) cell count were determined every 6 months. Questionnaires, pill counts, and plasma zinc and C-reactive protein levels were used to monitor adherence to study supplements and antiretroviral therapy. Intent-to-treat analysis used multiple-event analysis, treating CD4(+) cell count <200 cells/mm(3) as a recurrent immunological failure event. Cox proportional hazard models and the general-linear model were used to analyze morbidity and mortality data.


RESULTS
Zinc supplementation for 18 months reduced 4-fold the likelihood of immunological failure, controlling for age, sex, food insecurity, baseline CD4(+) cell count, viral load, and antiretroviral therapy (relative rate, 0.24; 95% confidence interval, 0.10-0.56; P<.002). Viral load indicated poor control with antiretroviral therapy but was not affected by zinc supplementation. Zinc supplementation also reduced the rate of diarrhea by more than half (odds ratio, 0.4; 95% confidence interval, 0.183-0.981; P=.019), compared with placebo. There was no significant difference in mortality between the 2 groups.


CONCLUSIONS
This study demonstrated that long-term (18-month) zinc supplementation at nutritional levels delayed immunological failure and decreased diarrhea over time. This evidence supports the use of zinc supplementation as an adjunct therapy for HIV-infected adult cohorts with poor viral control. Trial registration. ClinicalTrials.gov identifier: NCT00149552.
Baum
Marianna K
MK
Florida International University, R. Stempel College of Public Health and Social Work, Miami, Florida, USA. baumm@fiu.edu
Lai
Shenghan
S
Sales
Sabrina
S
Page
J Bryan
JB
Campa
Adriana
A
D000328:Adult; D018791:CD4 Lymphocyte Count; D019587:Dietary Supplements; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006801:Humans; D007154:Immune System Diseases / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D019562:Viral Load; D015032:Zinc / Q000172:deficiency / Q000627:therapeutic use*
D015032:Zinc
J Nutr. 2000 May;130(5S Suppl):1421S-3S
10801954
JAMA. 1988 May 20;259(19):2850-1
3367449
Clin Infect Dis. 2005 Aug 1;41(3):361-72
16007534
Clin Infect Dis. 2003;37 Suppl 2:S117-23
12942385
Lancet. 2005 Nov 26;366(9500):1862-7
16310552
J Acquir Immune Defic Syndr (1988). 1991;4(10):976-80
1890606
Curr Opin Pulm Med. 2004 May;10(3):176-82
15071368
J Med Virol. 2005 Jun;76(2):153-60
15834865
Curr HIV Res. 2008 Mar;6(2):100-7
18336257
J Infect Dis. 1997 Feb;175(2):247-54
9203644
AIDS. 1992 Jul;6(7):701-8
1503689
Biometrics. 1986 Mar;42(1):121-30
3719049
Clin Infect Dis. 2009 Feb 1;48(3):328-37
19123868
Pediatr Int. 2003 Oct;45(5):555-9
14521531
AIDS. 1995 Sep;9(9):1051-6
8527077
MMWR Recomm Rep. 2008 Dec 5;57(RR-10):1-12
19052530
Ann N Y Acad Sci. 1992 Apr 15;650:94-8
1605503
Am J Clin Nutr. 1997 Aug;66(2):460S-463S
9250133
Food Nutr Bull. 2007 Sep;28(3 Suppl):S403-29
17988005
AIDS Rev. 2006 Apr-Jun;8(2):88-97
16848276
Int J STD AIDS. 2008 Jun;19(6):410-3
18595880
Ann Intern Med. 2000 Sep 19;133(6):401-10
10975957
Am J Epidemiol. 1993 Dec 1;138(11):937-51
7903021
J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):197-201
16940855
Int J Immunopharmacol. 1995 Sep;17(9):719-27
8582783
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):475-82
17019373
N Engl J Med. 1995 Sep 28;333(13):839-44
7651474
Br J Nutr. 1993 Jan;69(1):243-55
8457531
Int Arch Allergy Immunol. 1993;101(2):126-31
8508050
J Pediatr. 1999 Aug;135(2 Pt 1):208-17
10431116
Postgrad Med J. 1990 Dec;66(782):1025-8
2128123
J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6
18645520
J Infect Dis. 1996 Jul;174(1):191-4
8655993
Stat Methods Med Res. 2007 Apr;16(2):103-22
17484295
J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93
16249702
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):272-8
9402074
AIDS. 2007 Jan 2;21(1):108-10
17148977
Br J Nutr. 2006 Apr;95(4):762-70
16571156